Prof. Dr. med. Hartmut Lode

Home » Publikationen

Publikationen

Auswahl

1: Lode H, Raffenberg M, Geerdes-Fenge H, Mauch H.
Monotherapy of nosocomial pneumonia.
Semin Respir Crit Care Med. 2000;21(1):9-18.
PMID: 16088714 [PubMed - in process]


2: Christensen D, Feldman C, Rossi P, Marrie T, Blasi F, Luna C, Fernandez P,
Porras J, Martinez J, Weiss K, Levy G, Lode H, Gross P, File T, Ramirez J;
Community-Acquired Pneumonia Organization Investigators.
HIV infection does not influence clinical outcomes in hospitalized patients
with bacterial community-acquired pneumonia: results from the CAPO international
cohort study.
Clin Infect Dis. 2005 Aug 15;41(4):554-6. Epub 2005 Jul 6.
PMID: 16028168 [PubMed - in process]


3: Pletz MW, Lode H.
Apoptosis of circulating neutrophils in COPD patients.
Chest. 2005 Apr;127(4):1464; author reply 1464-5. No abstract available.
PMID: 15821240 [PubMed - indexed for MEDLINE]


4: Groneberg DA, Poutanen SM, Low DE, Lode H, Welte T, Zabel P.
Treatment and vaccines for severe acute respiratory syndrome.
Lancet Infect Dis. 2005 Mar;5(3):147-55. Review.
PMID: 15766649 [PubMed - indexed for MEDLINE]


5: Rose M, Lode H, de Roux A, Zielen S.
[Pneumococcal vaccination in obstructive lung diseases -- what can we expect?]
Dtsch Med Wochenschr. 2005 Mar 4;130(9):461-5. Review. German.
PMID: 15731959 [PubMed - indexed for MEDLINE]


6: Allewelt M, Lode H.
[Diagnosis of haemoptoe/haemoptysis]
Dtsch Med Wochenschr. 2005 Mar 4;130(9):450-2. Review. German.
PMID: 15731957 [PubMed - indexed for MEDLINE]


7: Witt C, Lode H.
[Pneumology -- epidemiological changes and structural consequences]
Dtsch Med Wochenschr. 2005 Mar 4;130(9):439. German. No abstract available.
PMID: 15731953 [PubMed - indexed for MEDLINE]


8: Naber CK, Bauhofer A, Block M, Buerke M, Erbel R, Graninger W, Herrmann M,
Horstkotte D, Kern P, Lode H, Mehlhorn U, Meyer J, Mugge A, Niebel J, Peters G,
Shah PM, Werdan K.
[S2 guideline for infectious endocarditis]
MMW Fortschr Med. 2004 Dec 9;146(Suppl 3-4):123-35. Review. German.
PMID: 15662902 [PubMed - indexed for MEDLINE]


9: Zervos M, Mandell LA, Vrooman PS, Andrews CP, McIvor A, Abdulla RH, de
Caprariis PJ, Knirsch CA, Amsden GW, Niederman MS, Lode H.
Comparative efficacies and tolerabilities of intravenous azithromycin plus
ceftriaxone and intravenous levofloxacin with step-down oral therapy for
hospitalized patients with moderate to severe community-acquired pneumonia.

Treat Respir Med. 2004;3(5):329-36.
PMID: 15606222 [PubMed - indexed for MEDLINE]


10: Pletz MW, McGee L, Burkhardt O, Lode H, Klugman KP.
Ciprofloxacin treatment failure in a patient with resistant Streptococcus
pneumoniae infection following prior ciprofloxacin therapy.

Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):58-60.
PMID: 15592904 [PubMed - indexed for MEDLINE]


11: Forster-Waldl E, Riemer AB, Dehof AK, Neumann D, Bramswig K,
Boltz-Nitulescu G, Pehamberger H, Zielinski CC, Scheiner O, Pollak A, Lode H,
Jensen-Jarolim E.
Isolation and structural analysis of peptide mimotopes for the
disialoganglioside GD2, a neuroblastoma tumor antigen.

Mol Immunol. 2005 Feb;42(3):319-25.
PMID: 15589320 [PubMed - indexed for MEDLINE]


12: de Roux A, Schmidt N, Rose M, Zielen S, Pletz M, Lode H.
Immunogenity of the pneumococcal polysaccharide vaccine in COPD patients. The
effect of systemic steroids.

Respir Med. 2004 Dec;98(12):1187-94.
PMID: 15588039 [PubMed - indexed for MEDLINE]


13: Lode H, Eller J, Linnhoff A, Ioanas M;
Evaluation of Therapy-Free Interval in COPD Patients Study Group.
Levofloxacin versus clarithromycin in COPD exacerbation: focus on
exacerbation-free interval.

Eur Respir J. 2004 Dec;24(6):947-53.
PMID: 15572537 [PubMed - indexed for MEDLINE]


14: Pletz MW, Rau M, Bulitta J, De Roux A, Burkhardt O, Kruse G, Kurowski M,
Nord CE, Lode H.
Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison
to those of ceftriaxone, after multiple dosing in male and female volunteers.

Antimicrob Agents Chemother. 2004 Oct;48(10):3765-72.
PMID: 15388432 [PubMed - indexed for MEDLINE]


15: Voss M, Allewelt M, Lode H.
[Chronic eosinophilic pneumonia]
Dtsch Med Wochenschr. 2004 Sep 3;129(36):1858-60. German.
PMID: 15368157 [PubMed - indexed for MEDLINE]


16: Wutzler P, Kossow KD, Lode H, Ruf BR, Scholz H, Vogel GE; Expert Group,
German Association for the Control of Virus Diseases and Paul-Ehrlich Society of
Germany.
Antiviral treatment and prophylaxis of influenza in primary care: German
recommendations.

J Clin Virol. 2004 Oct;31(2):84-91.
PMID: 15364262 [PubMed - indexed for MEDLINE]


17: File TM Jr, Lode H, Kurz H, Kozak R, Xie H, Berkowitz E; 600 Study Group.
Double-blind, randomized study of the efficacy and safety of oral
pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams)
versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice
daily for 7 days, in treatment of bacterial community-acquired pneumonia in
adults.

Antimicrob Agents Chemother. 2004 Sep;48(9):3323-31.
PMID: 15328092 [PubMed - indexed for MEDLINE]


18: Schneider T, Ulrichs T, Loddenkemper C, Lode H, Zeitz M, Scherubl H.
[Intestinal tuberculosis: a clinical and diagnostic challenge]
Dtsch Med Wochenschr. 2004 Aug 13;129(33):1747-52. Review. German. No abstract
available.

PMID: 15295686 [PubMed - indexed for MEDLINE]


19: Lode H, Magyar P, Muir JF, Loos U, Kleutgens K; International Gatifloxacin
Study Group.
Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment
of patients with community-acquired pneumonia.

Clin Microbiol Infect. 2004 Jun;10(6):512-20.
PMID: 15191378 [PubMed - indexed for MEDLINE]


20: File TM Jr, Garau J, Blasi F, Chidiac C, Klugman K, Lode H, Lonks JR,
Mandell L, Ramirez J, Yu V.
Guidelines for empiric antimicrobial prescribing in community-acquired
pneumonia.

Chest. 2004 May;125(5):1888-901. Review.
PMID: 15136404 [PubMed - indexed for MEDLINE]


21: Lode H, Aronkyto T, Chuchalin AG, Jaaskevi M, Kahnovskii I, Kleutgens K;
International Gatifloxacin Study Group.
A randomised, double-blind, double-dummy comparative study of gatifloxacin with
clarithromycin in the treatment of community-acquired pneumonia.

Clin Microbiol Infect. 2004 May;10(5):403-8.
PMID: 15113316 [PubMed - indexed for MEDLINE]


22: Pletz MW, Ioanas M, de Roux A, Burkhardt O, Lode H.
Reduced spontaneous apoptosis in peripheral blood neutrophils during
exacerbation of COPD.

Eur Respir J. 2004 Apr;23(4):532-7.
PMID: 15083750 [PubMed - indexed for MEDLINE]


23: de Roux A, Marcos MA, Garcia E, Mensa J, Ewig S, Lode H, Torres A.
Viral community-acquired pneumonia in nonimmunocompromised adults.
Chest. 2004 Apr;125(4):1343-51.
PMID: 15078744 [PubMed - indexed for MEDLINE]


24: de Roux A, Lode H.
Recent developments in antibiotic treatment.
Infect Dis Clin North Am. 2003 Dec;17(4):739-51. Review.
PMID: 15008596 [PubMed - indexed for MEDLINE]


25: Pletz MW, De Roux A, Roth A, Neumann KH, Mauch H, Lode H.
Early bactericidal activity of moxifloxacin in treatment of pulmonary
tuberculosis: a prospective, randomized study.

Antimicrob Agents Chemother. 2004 Mar;48(3):780-2.
PMID: 14982764 [PubMed - indexed for MEDLINE]


26: Ioanas M, Lode H.
Linezolid in VAP by MRSA: a better choice?
Intensive Care Med. 2004 Mar;30(3):343-6. Epub 2004 Feb 6. No abstract
available.
PMID: 14767588 [PubMed - indexed for MEDLINE]


27: Allewelt M, Schuler P, Bolcskei PL, Mauch H, Lode H; Study Group on
Aspiration Pneumonia.
Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of
aspiration pneumonia and primary lung abscess.

Clin Microbiol Infect. 2004 Feb;10(2):163-70.
PMID: 14759242 [PubMed - indexed for MEDLINE]


28: Kuhnke A, Lode H.
[Problems of pharmacotherapy of infections in the aged]
Internist (Berl). 2003 Aug;44(8):986-94. German.
PMID: 14671813 [PubMed - indexed for MEDLINE]


29: Prokop A, Wrasidlo W, Lode H, Herold R, Lang F, Henze G, Dorken B, Wieder
T, Daniel PT.
Induction of apoptosis by enediyne antibiotic calicheamicin thetaII proceeds
through a caspase-mediated mitochondrial amplification loop in an entirely
Bax-dependent manner.

Oncogene. 2003 Dec 11;22(57):9107-20.
PMID: 14647446 [PubMed - indexed for MEDLINE]


30: Lode H, Grossman C, Choudhri S, Haverstock D, McGivern J, Herman-Gnjidic Z,
Church D.
Sequential IV/PO moxifloxacin treatment of patients with severe
community-acquired pneumonia.

Respir Med. 2003 Oct;97(10):1134-42.
PMID: 14561021 [PubMed - indexed for MEDLINE]


31: Burkhardt O, Allewelt M, Pletz MW, Welte T, Lode H.
Beau's lines in a patient treated with moxifloxacin for anaerobic pulmonary
infection.

Scand J Infect Dis. 2003;35(8):516-8.
PMID: 14514159 [PubMed - indexed for MEDLINE]


32: Lubasch A, Ziege S, Brodersen B, Borner K, Koeppe P, Lode H.
Serum bactericidal activity of trovafloxacin, in combination with cefepime or
amikacin, in healthy volunteers.

Clin Microbiol Infect. 2003 Jul;9(7):670-7.
PMID: 12925107 [PubMed - indexed for MEDLINE]


33: Lode H, Lubasch A, Raffenberg M, Mauch H.
Clinical results in the treatment of respiratory infections with moxifloxacin.
Drugs Today (Barc). 2000 Apr;36(4):245-53.
PMID: 12879120 [PubMed]


34: Burkhardt O, Merker HJ, Shakibaei M, Lode H.
Electron microscopic findings in BAL of a fire-eater after petroleum
aspiration.

Chest. 2003 Jul;124(1):398-400.
PMID: 12853552 [PubMed - indexed for MEDLINE]


35: Pletz MW, Petzold P, Allen A, Burkhardt O, Lode H.
Effect of calcium carbonate on bioavailability of orally administered
gemifloxacin.

Antimicrob Agents Chemother. 2003 Jul;47(7):2158-60.
PMID: 12821462 [PubMed - indexed for MEDLINE]


36: Polzin A, Pletz M, Erbes R, Raffenberg M, Mauch H, Wagner S, Arndt G, Lode
H.
Procalcitonin as a diagnostic tool in lower respiratory tract infections and
tuberculosis.

Eur Respir J. 2003 Jun;21(6):939-43.
PMID: 12797485 [PubMed - indexed for MEDLINE]


37: Soler M, Lode H, Baldwin R, Levine JH, Schreurs AJ, van Noord JA, Maesen
FP, Zehrer M; European Gatifloxacin Study group.
Randomised double-blind comparison of oral gatifloxacin and co-amoxiclav for
acute exacerbation of chronic Bronchitis.

Eur J Clin Microbiol Infect Dis. 2003 Mar;22(3):144-50. Epub 2003 Mar 5.
PMID: 12649711 [PubMed - indexed for MEDLINE]


38: Stahlmann R, Lode H.
Fluoroquinolones in the elderly: safety considerations.
Drugs Aging. 2003;20(4):289-302. Review.
PMID: 12641485 [PubMed - indexed for MEDLINE]


39: Lubasch A, Luck S, Lode H, Mauch H, Lorenz J, Bolcskei P, Welte T; COPD
Study Group.
Optimizing ceftazidime pharmacodynamics in patients with acute exacerbation of
severe chronic bronchitis.

J Antimicrob Chemother. 2003 Mar;51(3):659-64.
PMID: 12615868 [PubMed - indexed for MEDLINE]


40: Lode H, Allewelt M.
Role of newer fluoroquinolones in lower respiratory tract infections.
J Antimicrob Chemother. 2002 Jul;50(1):151-4. Review. No abstract available.
PMID: 12613473 [PubMed - indexed for MEDLINE]


41: Pletz MW, Preechachatchaval V, Bulitta J, Allewelt M, Burkhardt O, Lode H.
ABT-773: pharmacokinetics and interactions with ranitidine and sucralfate.
Antimicrob Agents Chemother. 2003 Mar;47(3):1129-31.
PMID: 12604553 [PubMed - indexed for MEDLINE]


42: Burkhardt O, Borner K, Stass H, Beyer G, Allewelt M, Nord CE, Lode H.
Single- and multiple-dose pharmacokinetics of oral moxifloxacin and
clarithromycin, and concentrations in serum, saliva and faeces.

Scand J Infect Dis. 2002;34(12):898-903.
PMID: 12587622 [PubMed - indexed for MEDLINE]


43: Lode H, File TM Jr, Mandell L, Ball P, Pypstra R, Thomas M; 185
Gemifloxacin Study Group.
Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral
cefuroxime with or without a macrolide in the treatment of patients hospitalized
with community-acquired pneumonia: a randomized, open-label, multicenter study
of clinical efficacy and tolerability.

Clin Ther. 2002 Nov;24(11):1915-36.
PMID: 12501883 [PubMed - indexed for MEDLINE]


44: Burkhardt O, Borner K, von der Hoh N, Koppe P, Pletz MW, Nord CE, Lode H.
Single- and multiple-dose pharmacokinetics of linezolid and co-amoxiclav in
healthy human volunteers.

J Antimicrob Chemother. 2002 Nov;50(5):707-12.
PMID: 12407127 [PubMed - indexed for MEDLINE]


45: Mainz D, Borner K, Koeppe P, Kotwas J, Lode H.
Pharmacokinetics of lansoprazole, amoxicillin and clarithromycin after
simultaneous and single administration.

J Antimicrob Chemother. 2002 Nov;50(5):699-706. Erratum in: J Antimicrob
Chemother. 2003 Feb;51(2):477.
PMID: 12407126 [PubMed - indexed for MEDLINE]


46: Vogel F, Scholz H, al-Nawas B, Elies W, Kresken M, Lode H, Muller O, Naber
KG, Petersen E, Shah P, Sorgel F, Stille W, Tauchnitz C, Trautmann M, Ullmann U,
Wacha H, Wiedemann B; Paul Ehrlich Society for Chemotherapy.
[Rational use of oral antibiotics. Findings of an expert commission of the Paul
Ehrlich Society for Chemotherapy.]

Med Monatsschr Pharm. 2002 Jun;25(6):193-204. German. No abstract available.
PMID: 12109028 [PubMed - indexed for MEDLINE]


47: Lode H.
Community-acquired lower respiratory tract infections: clinical experience with
beta-lactam/beta-lactamase inhibitors.

Int J Clin Pract Suppl. 2002 Mar;(125):10-17; discussion 37-9. Review.
PMID: 12014852 [PubMed - indexed for MEDLINE]


48: Lode H, Allewelt M.
Role of newer fluoroquinolones in lower respiratory tract infections.
J Antimicrob Chemother. 2002 May;49(5):709-12. Review. No abstract available.
Corrected and republished in: J Antimicrob Chemother. 2002 Jul;50(1):151-4.
PMID: 12003962 [PubMed - indexed for MEDLINE]


49: Lode H, Garau J.
Improving care for patients with respiratory tract infections.
J Chemother. 2002 Feb;14 Suppl 2:22-8. Review.
PMID: 12003137 [PubMed - indexed for MEDLINE]


50: Panknin HT, Lode H, Kresken M.
[Clinical significance of infections in geriatric patients in long-term nursing
care facilities]

Krankenpfl J. 2000 Jun;38(5):170-6. German. No abstract available.
PMID: 11992951 [PubMed - indexed for MEDLINE]


51: Lode H, Raffenberg M, Erbes R, Geerdes-Fenge H, Mauch H.
Nosocomial pneumonia: epidemiology, pathogenesis, diagnosis, treatment and
prevention.

Curr Opin Infect Dis. 2000 Aug;13(4):377-384.
PMID: 11964806 [PubMed - as supplied by publisher]


52: Grysczyk H, De Roux A, Grassot A, Mauch H, Lode H.
[Antimycotic treatment of pulmonary aspergilloma in patients without
neutropenia]

Dtsch Med Wochenschr. 2002 Mar 8;127(10):492-6. German.
PMID: 11884987 [PubMed - indexed for MEDLINE]


53: Lode H, Von der Hoh N, Ziege S, Borner K, Nord CE.
Ecological effects of linezolid versus amoxicillin/clavulanic acid on the
normal intestinal microflora.

Scand J Infect Dis. 2001;33(12):899-903.
PMID: 11868762 [PubMed - indexed for MEDLINE]


54: Fassbender M, Lode H, Schiller C, Andro R, Goetschi B, Borner K, Koeppe P.
Comparative pharmacokinetics of macrolide antibiotics and concentrations
achieved in polymorphonuclear leukocytes and saliva.

Clin Microbiol Infect. 1996 Jun;1(4):235-243.
PMID: 11866772 [PubMed - as supplied by publisher]


55: Lode H, Aubier M, Portier H, Ortqvist A.
Sparfloxacin as alternative treatment to standard therapy for
community-acquired bacteremic pneumococcal pneumonia.

Clin Microbiol Infect. 1998 Mar;4(3):135-143.
PMID: 11864307 [PubMed - as supplied by publisher]


56: Gutleben KJ, Eller J, Vockler J, Rau M, Koeppe P, Kotwas J, Lode H.
Pharmacokinetics of cefetamet pivoxil and interaction with cisapride and
N-acetylcysteine.

Clin Microbiol Infect. 1997 Apr;3(2):170-174.
PMID: 11864100 [PubMed - as supplied by publisher]


57: Hamacher J, Luepke J, Reidenberg BE, Nord CE, Borner K, Koeppe P, Bristol
D, Lode H.
Changes in fecal flora and comparative multiple-dose pharmacokinetics of
ceftibuten, cefpodoxime proxetil and amoxycillin/clavulanate.

Clin Microbiol Infect. 1999 Jun;5(6):339-354.
PMID: 11856279 [PubMed - as supplied by publisher]


58: Wrasidlo W, Schroder U, Bernt K, Hubener N, Shabat D, Gaedicke G, Lode H.
Synthesis, hydrolytic activation and cytotoxicity of etoposide prodrugs.
Bioorg Med Chem Lett. 2002 Feb 25;12(4):557-60.
PMID: 11844671 [PubMed - indexed for MEDLINE]


59: Denning DW, Ribaud P, Milpied N, Caillot D, Herbrecht R, Thiel E, Haas A,
Ruhnke M, Lode H.
Efficacy and safety of voriconazole in the treatment of acute invasive
aspergillosis.

Clin Infect Dis. 2002 Mar 1;34(5):563-71. Epub 2002 Jan 22.
PMID: 11807679 [PubMed - indexed for MEDLINE]


60: Allewelt M, Lode H.
[Diagnosis and therapy of abscess forming pneumonia]
Ther Umsch. 2001 Oct;58(10):599-603. German.
PMID: 11695090 [PubMed - indexed for MEDLINE]


61: Borner K, Borner E, Lode H.
Determination of linezolid in human serum and urine by high-performance liquid
chromatography.

Int J Antimicrob Agents. 2001 Sep;18(3):253-8.
PMID: 11673038 [PubMed - indexed for MEDLINE]


62: Lode H.
Role of sultamicillin and ampicillin/sulbactam in the treatment of upper and
lower bacterial respiratory tract infections.

Int J Antimicrob Agents. 2001 Sep;18(3):199-209. Review.
PMID: 11673031 [PubMed - indexed for MEDLINE]


63: Lode H.
Evidence of different profiles of side effects and drug-drug interactions among
the quinolones--the pharmacokinetic standpoint.

Chemotherapy. 2001;47 Suppl 3:24-31; discussion 44-8.
PMID: 11549786 [PubMed - indexed for MEDLINE]


64: Gastmeier P, Beck KD, Lode H.
[Respiratory filters and pneumonia: many unresolved questions]
Dtsch Med Wochenschr. 2001 Jul 27;126(30):835-9. Review. German.
PMID: 11512280 [PubMed - indexed for MEDLINE]


65: Lode H, Eller J, Raffenberg M, Mauch H.
Role of long-acting cephalosporins in the treatment of lower respiratory tract
infections.

Clin Microbiol Infect. 2000;6 Suppl 3:87-9. Review. No abstract available.
PMID: 11449664 [PubMed - indexed for MEDLINE]


66: Lubasch A, Erbes R, Mauch H, Lode H.
Sparfloxacin in the treatment of drug resistant tuberculosis or intolerance of
first line therapy.

Eur Respir J. 2001 Apr;17(4):641-6.
PMID: 11401058 [PubMed - indexed for MEDLINE]


67: Raffenberg M, Szymanski T, Lubasch A, Erbes R, Wagner S, Weist K, Mansmann
U, Lode H.
[Infections caused by Stenotrophomonas maltophilia (SMA) in intensive care
patients--a prospective case-control study]

Dtsch Med Wochenschr. 2001 May 4;126(18):514-8. German.
PMID: 11381633 [PubMed - indexed for MEDLINE]


68: Ruf BR, Lode H.
[Status of infectiology in Germany]
Dtsch Med Wochenschr. 2001 May 4;126(18):513. German. No abstract available.
PMID: 11381632 [PubMed - indexed for MEDLINE]


69: Lode H, Erbes R.
[Idiopathic pulmonary fibrosis. III. Case report]
Dtsch Med Wochenschr. 2001 Apr 6;126(14):401. German. No abstract available.
PMID: 11354052 [PubMed - indexed for MEDLINE]


70: Woske HJ, Roding T, Schulz I, Lode H.
Ventilator-associated pneumonia in a surgical intensive care unit:
epidemiology, etiology and comparison of three bronchoscopic methods for
microbiological specimen sampling.

Crit Care. 2001;5(3):167-73. Epub 2001 Apr 27.
PMID: 11353934 [PubMed - indexed for MEDLINE]


71: Lode H, Erbes R, Raffenberg M.
[Idiopathic pulmonary fibrosis. II. Treatment]
Dtsch Med Wochenschr. 2001 Apr 6;126(14):399-401. German. No abstract
available.
PMID: 11332243 [PubMed - indexed for MEDLINE]


72: Erbes R, Raffenberg M, Lode H.
[Idiopathic pulmonary fibrosis. I. Diagnosis]
Dtsch Med Wochenschr. 2001 Apr 6;126(14):395-8. German. No abstract available.
PMID: 11332242 [PubMed - indexed for MEDLINE]


73: Lode H, Erbes R, Geerdes-Fenge H, Raffenberg M, Mauch H.
[Nosocomial pneumonia. Epidemiology, pathogenesis and diagnosis]
Anaesthesist. 2001 Jan;50(1):46-51. Review. German. No abstract available.
PMID: 11220259 [PubMed - indexed for MEDLINE]


74: Drusano GL, Lode H, Edwards JR.
Meropenem: clinical response in relation to in vitro susceptibility.
Clin Microbiol Infect. 2000 Apr;6(4):185-94.
PMID: 11168106 [PubMed - indexed for MEDLINE]


75: Gluck T, Opal S, Alattar-Mantis J, Weitzel T, Lode H, Scholmerich J.
Differences between American and German medical students and physicians in
knowledge of infectious diseases.

Eur J Clin Microbiol Infect Dis. 2000 Nov;19(11):868-70.
PMID: 11152312 [PubMed - indexed for MEDLINE]


76: Lode H, Erbes R, Geerdes-Fenge H, Raffenberg M, Mauch H.
[Nosocomial pneumonia. Epidemiology, pathogenesis and diagnosis]
Internist (Berl). 2000 Nov;41(11):1170, 1173-6, 1178-9. Review. German. No
abstract available.
PMID: 11127220 [PubMed - indexed for MEDLINE]


77: Geerdes-Fenge HF, Wiedersich A, Wagner S, Lehr KH, Koeppe P, Lode H.
Levofloxacin pharmacokinetics and serum bactericidal activities against five
enterobacterial species.

Antimicrob Agents Chemother. 2000 Dec;44(12):3478-80.
PMID: 11083664 [PubMed - indexed for MEDLINE]


78: Ziege SU, Geerdes-Fenge HF, Rau M, Buchwald U, Lode H.
In vitro effects of interleukin-10, prednisolone, and GM-CSF on the
non-specific immune function of human polymorphonuclear leucocytes and
monocytes.

Eur J Med Res. 2000 Sep 18;5(9):369-74.
PMID: 11003971 [PubMed - indexed for MEDLINE]


79: Lubasch A, Keller I, Borner K, Koeppe P, Lode H.
Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin,
levofloxacin, trovafloxacin, and moxifloxacin after single oral administration
in healthy volunteers.

Antimicrob Agents Chemother. 2000 Oct;44(10):2600-3.
PMID: 10991830 [PubMed - indexed for MEDLINE]


80: Beyer G, Hiemer-Bau M, Ziege S, Edlund C, Lode H, Nord CE.
Impact of moxifloxacin versus clarithromycin on normal oropharyngeal
microflora.

Eur J Clin Microbiol Infect Dis. 2000 Jul;19(7):548-50.
PMID: 10968328 [PubMed - indexed for MEDLINE]


81: Gluck T, Geerdes-Fenge HF, Straub RH, Raffenberg M, Lang B, Lode H,
Scholmerich J.
Pneumocystis carinii pneumonia as a complication of immunosuppressive therapy.
Infection. 2000 Jul-Aug;28(4):227-30.
PMID: 10961529 [PubMed - indexed for MEDLINE]


82: File T, Schlemmer B, Garau J, Lode H, Lynch S, Young C.
Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute
exacerbations of chronic bronchitis. The 070 Clinical Study group.

J Chemother. 2000 Aug;12(4):314-25.
PMID: 10949981 [PubMed - indexed for MEDLINE]


83: Stahlmann R, Lode H.
[Recent fluoroquinolones. Highly effective weapons for ambulatory therapy]
MMW Fortschr Med. 1999 Nov 25;141(47):35-6. German. No abstract available.
PMID: 10912165 [PubMed - indexed for MEDLINE]


84: Lubasch A, Lode H.
[The role of antibiotic therapy in infectious enteritis]
Internist (Berl). 2000 May;41(5):494-7. Review. German. No abstract available.
PMID: 10867909 [PubMed - indexed for MEDLINE]


85: Lode H.
[Therapy recommendations for sarcoidosis]
Dtsch Med Wochenschr. 2000 Mar 3;125(9):252. Review. German. No abstract
available.
PMID: 10766554 [PubMed - indexed for MEDLINE]


86: Lubasch A, Lode H.
[Antibiotic therapy in cholecystitis, cholangitis and pancreatitis]
Internist (Berl). 2000 Feb;41(2 Pt 1):168-74. Review. German. No abstract
available.
PMID: 10743597 [PubMed - indexed for MEDLINE]


87: Lode H.
[Theme issue pneumology]
Dtsch Med Wochenschr. 2000 Feb 25;125(8):205. German. No abstract available.
PMID: 10723453 [PubMed - indexed for MEDLINE]


88: Edlund C, Beyer G, Hiemer-Bau M, Ziege S, Lode H, Nord CE.
Comparative effects of moxifloxacin and clarithromycin on the normal intestinal
microflora.

Scand J Infect Dis. 2000;32(1):81-5.
PMID: 10716083 [PubMed - indexed for MEDLINE]


89: Lode H.
[Infectology. Globalized resistant pathogens and new vaccines]
Dtsch Med Wochenschr. 1999 Dec 23;124(51-52):1553-5. German. No abstract
available.
PMID: 10664654 [PubMed - indexed for MEDLINE]


90: Lode H.
[Amoxicillin/clavulanic acid (875/125 mg). New pharmacodynamic aspects]
Dtsch Med Wochenschr. 1999 Dec 3;124(48):1459-61. Review. German. No abstract
available.
PMID: 10615328 [PubMed - indexed for MEDLINE]


91: Stahlmann R, Lode H.
Toxicity of quinolones.
Drugs. 1999;58 Suppl 2:37-42. Review.
PMID: 10553703 [PubMed - indexed for MEDLINE]


92: Gastmeier P, Lode H, Ruden H.
[What is the evidence in the prevention ventilator-associated pneumonia?
Evaluation of several controversial prevention measures in connection with
ventilation and suction systems]

Dtsch Med Wochenschr. 1999 Oct 22;124(42):1241-4. Review. German. No abstract
available.
PMID: 10572533 [PubMed - indexed for MEDLINE]


93: Lode H.
Potential interactions of the extended-spectrum fluoroquinolones with the CNS.
Drug Saf. 1999 Aug;21(2):123-35. Review.
PMID: 10456380 [PubMed - indexed for MEDLINE]


94: Borner K, Hartwig H, Lode H.
Determination of trovafloxacin in human body fluids by high-performance liquid
chromatography.

J Chromatogr A. 1999 Jun 18;846(1-2):175-80.
PMID: 10420609 [PubMed - indexed for MEDLINE]


95: Riecke K, Eller J, Gericke C, Lode H.
[Inpatient treatment costs of exacerbated chronic obstructive lung disease]
Pneumologie. 1999 Apr;53(4):199-206. German.
PMID: 10409862 [PubMed - indexed for MEDLINE]


96: Stahlmann R, Eller J, Lode H.
[New understanding in the study of infectious diseases. Report of the 25th
Ludwig Heilmeyer Symposium of the Society for the Advancement of Internal
Medicine]

Dtsch Med Wochenschr. 1999 May 28;124(21):670-3. German. No abstract available.


PMID: 10382548 [PubMed - indexed for MEDLINE]


97: Raffenberg M, Geerdes-Fenge H, Muller-Pawlowski H, Petri M, Schaberg T,
Loddenkemper R, Lode H.
[Invasive and non-invasive home ventilation--changes between 1982 and 1996]
Med Klin (Munich). 1999 Apr;94(1 Spec No):18-21. German.
PMID: 10373729 [PubMed - indexed for MEDLINE]


98: Lober S, Ziege S, Rau M, Schreiber G, Mignot A, Koeppe P, Lode H.
Pharmacokinetics of gatifloxacin and interaction with an antacid containing
aluminum and magnesium.

Antimicrob Agents Chemother. 1999 May;43(5):1067-71.
PMID: 10223915 [PubMed - indexed for MEDLINE]


99: Bradley JS, Garau J, Lode H, Rolston KV, Wilson SE, Quinn JP.
Carbapenems in clinical practice: a guide to their use in serious infection.
Int J Antimicrob Agents. 1999 Feb;11(2):93-100. Review.
PMID: 10221411 [PubMed - indexed for MEDLINE]


100: Lode H, Vogel F, Elies W.
Grepafloxacin: a review of its safety profile based on clinical trials and
postmarketing surveillance.

Clin Ther. 1999 Jan;21(1):61-74; discussion 1-2. Review.
PMID: 10090425 [PubMed - indexed for MEDLINE]


101: Lode H.
[Inhalational anticholinergic versus inhaled beta-mimetic drugs in COPD]
Internist (Berl). 1999 Jan;40(1):114. German. No abstract available.
PMID: 10086312 [PubMed - indexed for MEDLINE]


102: Buchwald UK, Geerdes-Fenge HF, Vockler J, Ziege S, Lode H.
Interleukin-10: effects on phagocytosis and adhesion molecule expression of
granulocytes and monocytes in a comparison with prednisolone.

Eur J Med Res. 1999 Mar 26;4(3):85-94.
PMID: 10085274 [PubMed - indexed for MEDLINE]


103: Stahlmann R, Lode H.
Safety of quinolones.
Lancet. 1998 Oct 17;352(9136):1313. No abstract available.
PMID: 9788487 [PubMed - indexed for MEDLINE]


104: Lode H, Borner K, Koeppe P.
Pharmacodynamics of fluoroquinolones.
Clin Infect Dis. 1998 Jul;27(1):33-9. Review.
PMID: 9675446 [PubMed - indexed for MEDLINE]


105: Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, Lode H.
Infective exacerbations of chronic bronchitis: relation between bacteriologic
etiology and lung function.

Chest. 1998 Jun;113(6):1542-8.
PMID: 9631791 [PubMed - indexed for MEDLINE]


106: Worth H, Adam D, Handrick W, Leupold W, Lode H, Loos U, Marre R, Mauch H,
Schaberg T, Shah P, Sill V, Wettengel R.
[Prevention and therapy of bronchial infections. Recommendations of the German
Respiratory League of the German Society of Pneumology]

Pneumologie. 1998 Apr;52(4):232-7. German. No abstract available.
PMID: 9610188 [PubMed - indexed for MEDLINE]


107: Worth H, Adam D, Handrick W, Leupold W, Lode H, Loos U, Marre R, Mauch H,
Schaberg T, Shah P, Sill V, Wettengel R.
[Prophylaxis and therapy of bronchial infections. Recommendations of the German
Airway League of the German Pulmonology Association]

Med Klin (Munich). 1997 Dec 15;92(12):699-704. German. No abstract available.
PMID: 9483912 [PubMed - indexed for MEDLINE]


108: Lode HM, Schaberg T, Raffenberg M, Mauch H.
Nosocomial pneumonia in the critical care unit.
Crit Care Clin. 1998 Jan;14(1):119-33. Review.
PMID: 9448982 [PubMed - indexed for MEDLINE]


109: Geerdes-Fenge HF, Goetschi B, Rau M, Borner K, Koeppe P, Wettich K, Lode
H.
Comparative pharmacokinetics of dirithromycin and erythromycin in normal
volunteers with special regard to accumulation in polymorphonuclear leukocytes
and in saliva.

Eur J Clin Pharmacol. 1997;53(2):127-33.
PMID: 9403284 [PubMed - indexed for MEDLINE]


110: Schaberg T, Theilacker C, Nitschke OT, Lode H.
Lymphocyte subsets in peripheral blood and smoking habits.
Lung. 1997;175(6):387-94.
PMID: 9330248 [PubMed - indexed for MEDLINE]


111: Allewelt M, Steinhoff D, Rahlwes M, Vogel-Hartmann H, Hoffken G, Schaberg
T, Lode H.
[Changes in the spectrum of the causative agents of community-acquired
pneumonias (1982-1992)]

Dtsch Med Wochenschr. 1997 Aug 22;122(34-35):1027-32. German.
PMID: 9312456 [PubMed - indexed for MEDLINE]


112: Zix JA, Geerdes-Fenge HF, Rau M, Vockler J, Borner K, Koeppe P, Lode H.
Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate.
Antimicrob Agents Chemother. 1997 Aug;41(8):1668-72.
PMID: 9257738 [PubMed - indexed for MEDLINE]


113: Riecke K, Wagner S, Eller J, Lode H, Schaberg T.
[Pulmonary melioidosis in a German Southeast Asia tourist]
Pneumologie. 1997 May;51(5):499-502. German.
PMID: 9265152 [PubMed - indexed for MEDLINE]


114: Wilson WR, Bouza E, Lode H, Mouton Y.
The use of cefotaxime for the treatment of common infections: in vitro,
pharmacokinetic and clinical considerations.

J Chemother. 1997 May;9 Suppl 2:5-18. Review.
PMID: 9248972 [PubMed - indexed for MEDLINE]


115: Schuler P, Zemper K, Borner K, Koeppe P, Schaberg T, Lode H.
Penetration of sparfloxacin and ciprofloxacin into alveolar macrophages,
epithelial lining fluid, and polymorphonuclear leucocytes.

Eur Respir J. 1997 May;10(5):1130-6.
PMID: 9163658 [PubMed - indexed for MEDLINE]


116: Petri MG, Konig J, Moecke HP, Gramm HJ, Barkow H, Kujath P, Dennhart R,
Schafer H, Meyer N, Kalmar P, Thulig P, Muller J, Lode H.
Epidemiology of invasive mycosis in ICU patients: a prospective multicenter
study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy,
Divisions of Mycology and Pneumonia Research.

Intensive Care Med. 1997 Mar;23(3):317-25.
PMID: 9083235 [PubMed - indexed for MEDLINE]


117: Lode H, Schaberg T, Raffenberg M.
[The therapy of nosocomial pneumonia]
Dtsch Med Wochenschr. 1997 Jan 24;122(4):93-6. Review. German. No abstract
available.
PMID: 9072478 [PubMed - indexed for MEDLINE]


118: Schaberg T, Lode H.
[The diagnosis of nosocomial pneumonia]
Dtsch Med Wochenschr. 1997 Jan 17;122(3):61-4. Review. German. No abstract
available.
PMID: 9072466 [PubMed - indexed for MEDLINE]


119: Erbes R, Wagner A, Schaberg T, Lode H, Mauch H, Witte W.
[MRSA (methicillin-resistant Staphylococcus aureus) infections in patients with
pulmonary diseases]

Pneumologie. 1996 Oct;50(10):706-11. German.
PMID: 9019751 [PubMed - indexed for MEDLINE]


120: Schaberg T, Rebhan K, Lode H.
Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in
patients hospitalized for pulmonary tuberculosis.

Eur Respir J. 1996 Oct;9(10):2026-30.
PMID: 8902462 [PubMed - indexed for MEDLINE]


121: Lode H, Schaberg T.
[Pneumonia]
Pneumologie. 1996 Sep;50 Suppl 2:592-4. Review. German. No abstract available.
PMID: 9157422 [PubMed - indexed for MEDLINE]


122: Lode H, Steinhoff D, Schaberg T, Mauch H.
[New pneumonia pathogens, especially Chlamydia pneumoniae and Hantaviruses]
Internist (Berl). 1996 Sep;37(9):882-9. Review. German. No abstract available.
PMID: 8964681 [PubMed - indexed for MEDLINE]


123: Muller-Pawlowski H, Raffenberg M, Schaberg T, Petri M, Lode H.
[Intermittent nasal positive pressure ventilation with a ventilator in
accordance with the Medical Device Regulation III (MedGV III). Clinical
experiences with the BREAS PV 201 in 19 patients]

Pneumologie. 1996 Aug;50(8):518-22. German.
PMID: 8975243 [PubMed - indexed for MEDLINE]


124: Lode H, Borner K, Koeppe P, Schaberg T.
Azithromycin--review of key chemical, pharmacokinetic and microbiological
features.

J Antimicrob Chemother. 1996 Jun;37 Suppl C:1-8. Review.
PMID: 8818841 [PubMed - indexed for MEDLINE]


125: Steinhoff D, Lode H, Ruckdeschel G, Heidrich B, Rolfs A, Fehrenbach FJ,
Mauch H, Hoffken G, Wagner J.
Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized
patients in Berlin.

Clin Infect Dis. 1996 Jun;22(6):958-64.
PMID: 8783693 [PubMed - indexed for MEDLINE]


126: Adam D, Grimm H, Lode H.
Re: A. Bauernfeind et al.: Comparative pharmacodynamics of clarithromycin and
azithromycin against respiratory pathogens
(Infection 23 [1995] 316-321)
Infection. 1996 May-Jun;24(3):270-1. No abstract available.
PMID: 8811372 [PubMed - indexed for MEDLINE]


127: Aubier M, Lode H, Gialdroni-Grassi G, Huchon G, Hosie J, Legakis N,
Regamey C, Segev S, Vester R, Wijnands WJ, Tolstuchow N.
Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data
analysis of two studies.

J Antimicrob Chemother. 1996 May;37 Suppl A:73-82.
PMID: 8737127 [PubMed - indexed for MEDLINE]


128: Strauss LG, Kabelitz D, Kremer B, Lode H, Meinertz T, Sauerbruch T, Sterry
W.
[Use of positron-emission tomography in oncology]
Dtsch Med Wochenschr. 1996 Feb 16;121(7):207-9. German. No abstract available.
PMID: 8681765 [PubMed - indexed for MEDLINE]


129: Schulin T, Schaberg T, Lode H.
[Therapy of lung abscesses]
Dtsch Med Wochenschr. 1996 Feb 2;121(5):137-8. Review. German. No abstract
available.
PMID: 8717197 [PubMed - indexed for MEDLINE]


130: Schulin T, Schaberg T, Lode H.
[Diagnosis of lung abscesses]
Dtsch Med Wochenschr. 1996 Feb 2;121(5):135-6. Review. German. No abstract
available.
PMID: 8717196 [PubMed - indexed for MEDLINE]


131: Lode H.
[Sputum gram staining in pneumonia]
Dtsch Med Wochenschr. 1996 Jan 26;121(4):114-5. German. No abstract available.
PMID: 8631239 [PubMed - indexed for MEDLINE]


132: Schaberg T, Rau M, Oerter R, Liebers U, Rahn W, Kaiser D, Witt C, Lode H.
Expression of adhesion molecules in peripheral pulmonary vessels from smokers
and nonsmokers.

Lung. 1996;174(2):71-81.
PMID: 8919431 [PubMed - indexed for MEDLINE]


133: Dreetz M, Hamacher J, Eller J, Borner K, Koeppe P, Schaberg T, Lode H.
Serum bactericidal activities and comparative pharmacokinetics of meropenem and
imipenem-cilastatin.

Antimicrob Agents Chemother. 1996 Jan;40(1):105-9.
PMID: 8787889 [PubMed - indexed for MEDLINE]


134: Schaberg T, Gloger G, Reichert B, Mauch H, Lode H.
[Resistant lung tuberculosis in Berlin 1987-1993]
Pneumologie. 1996 Jan;50(1):21-7. German.
PMID: 8774931 [PubMed - indexed for MEDLINE]


135: Lode H, Garau J, Grassi C, Hosie J, Huchon G, Legakis N, Segev S, Wijnands
G.
Treatment of community-acquired pneumonia: a randomized comparison of
sparfloxacin, amoxycillin-clavulanic acid and erythromycin.

Eur Respir J. 1995 Dec;8(12):1999-2007.
PMID: 8666093 [PubMed - indexed for MEDLINE]


136: Rolfs A, Beige J, Finckh U, Kohler B, Schaberg T, Lokies J, Lode H.
Amplification of Mycobacterium tuberculosis from peripheral blood.
J Clin Microbiol. 1995 Dec;33(12):3312-4.
PMID: 8586724 [PubMed - indexed for MEDLINE]


137: Schaberg T, Reichert B, Schulin T, Lode H, Mauch H.
Rapid drug susceptibility testing of Mycobacterium tuberculosis using
conventional solid media.

Eur Respir J. 1995 Oct;8(10):1688-93.
PMID: 8586123 [PubMed - indexed for MEDLINE]


138: Lode H, Schaberg T, Raffenberg M, Mauch H.
Lower respiratory tract infections in the intensive care unit: consequences of
antibiotic resistance for choice of antibiotic.

Microb Drug Resist. 1995 Summer;1(2):163-7. Review.
PMID: 9158751 [PubMed - indexed for MEDLINE]


139: Hamacher J, Vogel F, Lichey J, Kohl FV, Diwok K, Wendel H, Lode H.
Treatment of acute bacterial exacerbations of chronic obstructive pulmonary
disease in hospitalised patients--a comparison of meropenem and
imipenem/cilastatin. COPD Study Group.

J Antimicrob Chemother. 1995 Jul;36 Suppl A:121-33.
PMID: 8543488 [PubMed - indexed for MEDLINE]


140: Hof H, Lode H.
[A single dosage of aminoglycosides?]
Dtsch Med Wochenschr. 1995 Jun 23;120(25-26):935-7. Review. German. No abstract
available.
PMID: 7600931 [PubMed - indexed for MEDLINE]


141: Schaberg T, Schonfeld N, Loddenkemper R, Lode H.
[Therapy of sarcoidosis]
Dtsch Med Wochenschr. 1995 May 19;120(20):725-7. Review. German. No abstract
available.
PMID: 7758412 [PubMed - indexed for MEDLINE]


142: Schonfeld N, Schaberg T, Lode H, Loddenkemper R.
[Diagnosis of sarcoidosis]
Dtsch Med Wochenschr. 1995 May 12;120(19):687-9. Review. German. No abstract
available.
PMID: 7768164 [PubMed - indexed for MEDLINE]


143: Schaberg T, Klein U, Rau M, Eller J, Lode H.
Subpopulations of alveolar macrophages in smokers and nonsmokers: relation to
the expression of CD11/CD18 molecules and superoxide anion production.

Am J Respir Crit Care Med. 1995 May;151(5):1551-8.
PMID: 7735614 [PubMed - indexed for MEDLINE]


144: Stuht H, Lode H, Koeppe P, Rost KL, Schaberg T.
Interaction study of lomefloxacin and ciprofloxacin with omeprazole and
comparative pharmacokinetics.

Antimicrob Agents Chemother. 1995 May;39(5):1045-9.
PMID: 7625786 [PubMed - indexed for MEDLINE]


145: Rubinstein E, Lode H, Grassi C.
Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious
hospital-acquired gram-negative infections. Antibiotic Study Group.

Clin Infect Dis. 1995 May;20(5):1217-28. Erratum in: Clin Infect Dis 1995
Jun;20(6):1582.
PMID: 7620002 [PubMed - indexed for MEDLINE]


146: Lode H.
Cefotaxime for the 1990s.
Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):1-3. No abstract available.
PMID: 7587021 [PubMed - indexed for MEDLINE]


147: Lode H, Schaberg T, Stahlmann R.
Selective decontamination of the digestive tract: indications and problems.
Infection. 1995 May-Jun;23(3):129-32. Review. No abstract available.
PMID: 7498999 [PubMed - indexed for MEDLINE]


148: Gramm HJ, Hannemann L, Reinhart K, Lode H.
[Sepsis: a conception in change. Possibilities and limitations of diagnosis
based on clinical criteria]

Dtsch Med Wochenschr. 1995 Apr 7;120(14):498-502. Review. German. No abstract
available.
PMID: 7712946 [PubMed - indexed for MEDLINE]


149: Bittner RC, Schnoy N, Schonfeld N, Grassot A, Loddenkemper R, Lode H,
Kaiser D, Krumhaar D, Felix R.
[High-resolution magnetic resonance tomography (HR-MRT) of the pleura and
thoracic wall: normal findings and pathological changes]

Rofo. 1995 Apr;162(4):296-303. German.
PMID: 7749084 [PubMed - indexed for MEDLINE]


150: Muller-Pawlowski H, von Moers A, Raffenberg M, Petri M, Saalfeld S, Lode
H.
[BiPAP therapy of respiratory disorders in patients with congenital
neuromuscular diseases]

Med Klin (Munich). 1995 Apr;90(1 Suppl 1):35-8. German.
PMID: 7616916 [PubMed - indexed for MEDLINE]


151: Schaberg T, Gloger G, Reichert B, Mauch H, Lode H.
Drug-resistant pulmonary tuberculosis in Berlin, Germany, 1987-1993.
Eur Respir J. 1995 Feb;8(2):278-84.
PMID: 7758564 [PubMed - indexed for MEDLINE]


152: Schaberg T, Lode H.
[Diagnosis of pulmonary infections]
Internist (Berl). 1995 Feb;36(2):146-50. Review. German. No abstract available.
PMID: 7737804 [PubMed - indexed for MEDLINE]


153: Lode H, Hamacher J, Eller J, Schaberg T.
Changing role of carbapenems in the treatment of lower respiratory tract
infections.

Scand J Infect Dis Suppl. 1995;96:17-23. Review.
PMID: 7652498 [PubMed - indexed for MEDLINE]


154: Beige J, Lokies J, Schaberg T, Finckh U, Fischer M, Mauch H, Lode H,
Kohler B, Rolfs A.
Clinical evaluation of a Mycobacterium tuberculosis PCR assay.
J Clin Microbiol. 1995 Jan;33(1):90-5.
PMID: 7535316 [PubMed - indexed for MEDLINE]


155: Ziegler D, Lode H, Raffenberg M, Schaberg T, Mauch H, Grassot A.
[Incompatibility of tuberculosis therapy in a patient with AIDS]
Dtsch Med Wochenschr. 1994 Dec 16;119(50):1728-33. German.
PMID: 8001464 [PubMed - indexed for MEDLINE]


156: Schaberg T, Lode H.
[Immunization in pneumology]
Pneumologie. 1994 Aug;48(8):505-10. Review. German. No abstract available.
PMID: 7971886 [PubMed - indexed for MEDLINE]


157: Schaberg T, Orzechowski K, Oesterling C, Lode H, Schuppan D.
Simultaneous measurement of collagen type-VI-related antigen and procollagen
type-III-N-propeptide levels in bronchoalveolar lavage.

Eur Respir J. 1994 Jul;7(7):1221-6.
PMID: 7925898 [PubMed - indexed for MEDLINE]


158: Eller J, Lapa e Silva JR, Poulter LW, Lode H, Cole PJ.
Cells and cytokines in chronic bronchial infection.
Ann N Y Acad Sci. 1994 May 28;725:331-45. No abstract available.
PMID: 8031005 [PubMed - indexed for MEDLINE]


159: Ritz M, Lode H, Fassbender M, Borner K, Koeppe P, Nord CE.
Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal
flora.

Antimicrob Agents Chemother. 1994 Mar;38(3):455-9.
PMID: 8203837 [PubMed - indexed for MEDLINE]


160: Raffenberg M, Schaberg T, Muller-Pawlowski H, Lode H.
[Indications for and use of home artificial respiration]
Dtsch Med Wochenschr. 1994 Feb 11;119(6):187-91. Review. German. No abstract
available.
PMID: 8306854 [PubMed - indexed for MEDLINE]


161: Lode H, Fassbender M, Schaberg T, Borner K, Koeppe P.
Comparative pharmacokinetics of the new oral cephalosporins.
Drugs. 1994;47 Suppl 3:10-9; discussion 19-20. Review.

PMID: 7518762 [PubMed - indexed for MEDLINE]


162: Lode H.
[The treatment of multiply resistant pulmonary tuberculosis]
Dtsch Med Wochenschr. 1993 Nov 19;118(46):1706-7. German. No abstract
available.
PMID: 8243246 [PubMed - indexed for MEDLINE]


163: Schaberg T, Lode H.
[Influenza infection and antibiotic therapy]
Dtsch Med Wochenschr. 1993 Nov 12;118(45):1663. German. No abstract available.
PMID: 8223228 [PubMed - indexed for MEDLINE]


164: Eller JM, Schaberg T, Lode H.
[The therapy of bronchiectasis]
Dtsch Med Wochenschr. 1993 Nov 5;118(44):1608-10. Review. German. No abstract
available.
PMID: 8223215 [PubMed - indexed for MEDLINE]


165: Eller JM, Schaberg T, Lode H.
[The clinical picture and diagnosis of bronchiectasis]
Dtsch Med Wochenschr. 1993 Nov 5;118(44):1605-7. Review. German. No abstract
available.
PMID: 8223214 [PubMed - indexed for MEDLINE]


166: Dennhardt R, Gramm HJ, Wiegand-Lohnert C, Lode H.
[Antimycotic therapy on intensive care units: contra]
Anasthesiol Intensivmed Notfallmed Schmerzther. 1993 Nov;28(7):453-6. German.
No abstract available.
PMID: 8297954 [PubMed - indexed for MEDLINE]


167: Schaberg T, Mauch H, Lode H.
[The clinical significance of penicillin-resistant pneumococci]
Dtsch Med Wochenschr. 1993 Oct 15;118(41):1491-7. Review. German. No abstract
available.
PMID: 8404510 [PubMed - indexed for MEDLINE]


168: Schaberg T, Lode H.
[Influenza infection and antibiotic therapy]
Dtsch Med Wochenschr. 1993 Oct 8;118(40):1464. German. No abstract available.
PMID: 8404503 [PubMed - indexed for MEDLINE]


169: Gunther J, Lode H, Raffenberg M, Schaberg T.
Development of pleural and pericardial effusions during itraconazole therapy of
pulmonary aspergillosis.

Eur J Clin Microbiol Infect Dis. 1993 Sep;12(9):723-4. No abstract available.
PMID: 8243493 [PubMed - indexed for MEDLINE]


170: Paulfeuerborn W, Muller HJ, Borner K, Koeppe P, Lode H.
Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and
ceftazidime.

Antimicrob Agents Chemother. 1993 Sep;37(9):1835-41.
PMID: 8239592 [PubMed - indexed for MEDLINE]


171: Lode H, Schaberg T, Raffenberg M, Mauch H.
Diagnostic problems in lower respiratory tract infections.
J Antimicrob Chemother. 1993 Jul;32 Suppl A:29-37. Review.
PMID: 8407697 [PubMed - indexed for MEDLINE]


172: Schaberg T, Rau M, Stephan H, Lode H.
Increased number of alveolar macrophages expressing surface molecules of the
CD11/CD18 family in sarcoidosis and idiopathic pulmonary fibrosis is related to
the production of superoxide anions by these cells.

Am Rev Respir Dis. 1993 Jun;147(6 Pt 1):1507-13.
PMID: 8099261 [PubMed - indexed for MEDLINE]


173: Borner K, Borner E, Lode H.
Determination of a new cephalosporin, SCE-2787, in serum and urine by
high-performance liquid chromatography.

J Chromatogr. 1993 May 19;615(1):174-9.
PMID: 8340458 [PubMed - indexed for MEDLINE]


174: Schneider T, Jahn HU, Steinhoff D, Guschoreck HM, Liesenfeld O, Mater-Bohm
H, Wesirow AL, Lode H, Ludwig WD, Dissmann T, et al.
[A Q fever epidemic in Berlin. The epidemiological and clinical aspects]
Dtsch Med Wochenschr. 1993 May 14;118(19):689-95. German.
PMID: 8500412 [PubMed - indexed for MEDLINE]


175: Fassbender M, Lode H, Schaberg T, Borner K, Koeppe P.
Pharmacokinetics of new oral cephalosporins, including a new carbacephem.
Clin Infect Dis. 1993 May;16(5):646-53. Review.
PMID: 8507756 [PubMed - indexed for MEDLINE]


176: Lode H, Schaberg T.
Rational approach to the diagnosis of Pneumocystis carinii pneumonia (PCP)
Eur Respir J. 1993 Feb;6(2):166-8. No abstract available.
PMID: 8444287 [PubMed - indexed for MEDLINE]


177: Deppermann KM, Lode H.
Fluoroquinolones: interaction profile during enteral absorption.
Drugs. 1993;45 Suppl 3:65-72. Review.
PMID: 7689454 [PubMed - indexed for MEDLINE]


178: Geerdes HF, Ziegler D, Lode H, Hund M, Loehr A, Fangmann W, Wagner J.
Septicemia in 980 patients at a university hospital in Berlin: prospective
studies during 4 selected years between 1979 and 1989.

Clin Infect Dis. 1992 Dec;15(6):991-1002.
PMID: 1457672 [PubMed - indexed for MEDLINE]


179: Schaberg T, Lode H.
[Therapy of pulmonary mycoses]
Dtsch Med Wochenschr. 1992 Nov 6;117(45):1725-9. Review. German. No abstract
available.
PMID: 1330477 [PubMed - indexed for MEDLINE]


180: Schaberg T, Lauer C, Lode H, Fischer J, Haller H.
Increased number of alveolar macrophages expressing adhesion molecules of the
leukocyte adhesion molecule family in smoking subjects. Association with
cell-binding ability and superoxide anion production.

Am Rev Respir Dis. 1992 Nov;146(5 Pt 1):1287-93.
PMID: 1359819 [PubMed - indexed for MEDLINE]


181: Schaberg T, Mauch H, Lode H.
[The clinical picture and diagnosis of pulmonary mycoses]
Dtsch Med Wochenschr. 1992 Oct 30;117(44):1681-4. Review. German. No abstract
available.
PMID: 1425273 [PubMed - indexed for MEDLINE]


182: Schaberg T, Lode H.
[Therapy of urogenital tuberculosis]
Dtsch Med Wochenschr. 1992 Sep 11;117(37):1418-9. German. No abstract
available.
PMID: 1516541 [PubMed - indexed for MEDLINE]


183: Borner K, Borner E, Lode H.
Determination of sparfloxacin in serum and urine by high-performance liquid
chromatography.

J Chromatogr. 1992 Sep 2;579(2):285-9.
PMID: 1331140 [PubMed - indexed for MEDLINE]


184: Roller S, Lode H, Stelzer I, Deppermann KM, Boeckh M, Koeppe P.
Pharmacokinetics of loracarbef and interaction with acetylcysteine.
Eur J Clin Microbiol Infect Dis. 1992 Sep;11(9):851-5.
PMID: 1468429 [PubMed - indexed for MEDLINE]


185: Bacher K, Schaeffer M, Lode H, Nord CE, Borner K, Koeppe P.
Multiple dose pharmacokinetics, safety, and effects on faecal microflora, of
cefepime in healthy volunteers.

J Antimicrob Chemother. 1992 Sep;30(3):365-75.
PMID: 1452502 [PubMed - indexed for MEDLINE]


186: Schaberg T, Lode H.
[Ambulant atypical pneumonia: clinical diagnosis and therapy]
Immun Infekt. 1992 Aug;20(4):136-7. Review. German.
PMID: 1398735 [PubMed - indexed for MEDLINE]


187: Lode H, Schaberg T, Hoffken G.
[Chemotherapeutic prevention of infection in invasive interventions in
high-risk internal medicine patients]

Internist (Berl). 1992 Jun;33(6):418-24. Review. German. No abstract available.
PMID: 1628928 [PubMed - indexed for MEDLINE]


188: Boeckh M, Lode H, Hoffken G, Daeschlein S, Koeppe P.
Pharmacokinetics of roxithromycin and influence of H2-blockers and antacids on
gastrointestinal absorption.

Eur J Clin Microbiol Infect Dis. 1992 May;11(5):465-8.
PMID: 1425718 [PubMed - indexed for MEDLINE]


189: Adam D, Ferlinz R, Frei R, Geisler L, Knothe H, Lode H, Shah P.
[Antibacterial therapy in infectious bronchial diseases. Recommendations of the
German League for control of respiratory tract diseases]

Med Monatsschr Pharm. 1992 Apr;15(4):100-5. Review. German. No abstract
available.
PMID: 1584110 [PubMed - indexed for MEDLINE]


190: Saathoff N, Lode H, Neider K, Depperman KM, Borner K, Koeppe P.
Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and
an H2 receptor antagonist.

Antimicrob Agents Chemother. 1992 Apr;36(4):796-800.
PMID: 1354432 [PubMed - indexed for MEDLINE]


191: Schaberg T, Haller H, Rau M, Kaiser D, Fassbender M, Lode H.
Superoxide anion release induced by platelet-activating factor is increased in
human alveolar macrophages from smokers.

Eur Respir J. 1992 Apr;5(4):387-93.
PMID: 1314191 [PubMed - indexed for MEDLINE]


192: Lode H, Schaberg T, Lebahn H.
[Value of serum bactericidal test for the treatment of infection]
Med Klin (Munich). 1992 Feb 15;87(2):94-5. German. No abstract available.
PMID: 1542290 [PubMed - indexed for MEDLINE]


193: Schaberg T, Witt C, Lode H.
[Bronchoscopic diagnosis of pneumonia]
Z Arztl Fortbild (Jena). 1992 Jan 31;86(1-2):57-62. German. No abstract
available.
PMID: 1546488 [PubMed - indexed for MEDLINE]


194: Lode H, Hoffken G, Kemmerich B, Schaberg T.
Systemic and endotracheal antibiotic prophylaxis of nosocomial pneumonia in
ICU.

Intensive Care Med. 1992;18 Suppl 1:S24-7. Review.
PMID: 1640029 [PubMed - indexed for MEDLINE]


195: Lode H, Muller C, Borner K, Nord CE, Koeppe P.
Multiple-dose pharmacokinetics of cefprozil and its impact on intestinal flora
of volunteers.

Antimicrob Agents Chemother. 1992 Jan;36(1):144-9.
PMID: 1590680 [PubMed - indexed for MEDLINE]


196: Lode H, Schaberg T.
Azithromycin in lower respiratory tract infections.
Scand J Infect Dis Suppl. 1992;83:26-33. Review.
PMID: 1336893 [PubMed - indexed for MEDLINE]


197: Schaberg T, Lode H.
[The antibiotic therapy of community-acquired pneumonias]
Dtsch Med Wochenschr. 1991 Dec 13;116(50):1917-20. Review. German. No abstract
available.
PMID: 1748070 [PubMed - indexed for MEDLINE]


198: Schaberg T, Lode H.
[Clinical aspects and diagnosis of community-acquired pneumonia]
Dtsch Med Wochenschr. 1991 Dec 6;116(49):1877-80. Review. German. No abstract
available.
PMID: 1743098 [PubMed - indexed for MEDLINE]


199: Vogel F, Lode H.
The use of oral temafloxacin compared with a parenteral cephalosporin in
hospitalized patients with pneumonia.

J Antimicrob Chemother. 1991 Dec;28 Suppl C:81-6.
PMID: 1664833 [PubMed - indexed for MEDLINE]


200: Haller H, Schaberg T, Lindschau C, Lode H, Distler A.
Endothelin increases [Ca2+]i, protein phosphorylation, and O2-. production in
human alveolar macrophages.

Am J Physiol. 1991 Dec;261(6 Pt 1):L478-84.
PMID: 1662920 [PubMed - indexed for MEDLINE]


© Prof. Dr. H. Lode | Feedback |
Stand: 2015